GRIm Score Predicts Nivolumab Efficacy in Melanoma
In the realm of oncology, the quest to improve patient outcomes in advanced malignant melanoma is both critical and complex. ...
Tag: nivolumab
NADIM ADJUVANT Trial Highlights Advantages of Chemo-Immunotherapy After Surgery in Stage IB–IIIA NSCLC
Interim findings from the NADIM ADJUVANT Phase III clinical trial conducted by the Spanish Lung Cancer Group (GECP) have unveiled ...
Chemo-Immunotherapy Exhibits Promising Efficacy in Advanced HPV-Negative Head and Neck Cancer Patients
Researchers at the University of Chicago Medicine Comprehensive Cancer Center are redefining the therapeutic landscape for advanced head and neck ...
